|
⚲
|
| Keyboard |
| Boucher Kelley
✚
|
|
|---|---|
| CIK # | 0002070437 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002070437] | |
| 4 | [0002070437] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apellis Pharmaceuticals Inc | |
| Boucher Kelley |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-28 | Grant | 30,146 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-06-09 | Grant | 45,095 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Grant | 67,396 | $19.39 | 1,306,808 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-05-28 | Grant | 22,087 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 32,976 | $16.80 | 553,997 |